Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS)

The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain...

Full description

Saved in:
Bibliographic Details
Published inBiology of sex differences Vol. 14; no. 1; pp. 21 - 13
Main Authors Escobar-Morreale, Héctor F., Martínez-García, M. Ángeles, Insenser, María, Cañellas, Nicolau, Correig, Xavier, Luque-Ramírez, Manuel
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 19.04.2023
BioMed Central
BMC
Subjects
Androgens
Body fat
Body mass index
Carbohydrates
Comorbidity
Estrogens
Female
Humans
Insulin resistance
Magnetic Resonance Spectroscopy
Male
Metabolism
Metabolites
Metabolomics
NMR
Nuclear magnetic resonance
Nuclear magnetic resonance spectroscopy
Obesity
Obesity - metabolism
Ovaries
Physiological aspects
Polycystic Ovary Syndrome
Protons
Sex
Sex Characteristics
Sex hormones
Sexual dimorphism
Stein-Leventhal syndrome
Type 2 diabetes
Young Adult
Young adults
Germany
Obesity
Polycystic ovary syndrome
Androgens
Metabolism
Estrogens
Sex
Online AccessGet full text

Cover

Abstract The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity. Participants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index ≥ 30 kg/m . Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling. Obesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts. Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.
AbstractList The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity. Obesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts. Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.
Background The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity. Methods Participants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index [greater than or equal to] 30 kg/m.sup.2. Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling. Results Obesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts. Conclusions Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism. Keywords: Androgens, Estrogens, Metabolism, Obesity, Polycystic ovary syndrome, Sex
Abstract Background The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity. Methods Participants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index ≥ 30 kg/m2. Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling. Results Obesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts. Conclusions Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.
BackgroundThe polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity.MethodsParticipants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index ≥ 30 kg/m2. Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling.ResultsObesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts.ConclusionsSerum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.
The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity.BACKGROUNDThe polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity.Participants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index ≥ 30 kg/m2. Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling.METHODSParticipants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index ≥ 30 kg/m2. Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling.Obesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts.RESULTSObesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts.Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.CONCLUSIONSSerum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.
The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using state-of-the art proton nuclear magnetic resonance spectroscopy metabolomics profiling, that androgen excess in women induces also a certain masculinization of intermediate metabolism that is modulated by obesity. Participants were 53 Caucasian young adults, including 17 women with classic PCOS consisting of hyperandrogenism and ovulatory dysfunction, 17 non-hyperandrogenic women presenting with regular menses, and 19 healthy men, selected in order to be similar in terms of age and body mass index (BMI). Half of the subjects had obesity defined by a body mass index ≥ 30 kg/m . Subjects maintained the same diet unrestricted in carbohydrates for 3 days before sampling and maintained their lifestyle and exercise patterns prior and during the study. Plasma samples were submitted to proton nuclear magnetic resonance spectroscopy metabolomics profiling. Obesity associated a metabolomics profile mainly characterized by increased branched chain and aromatic aminoacids. Regardless of obesity, this unfavorable profile also characterized men as compared with control women, and was shared by women with PCOS. Notably, the negative impact of obesity on metabolomics profile was restricted to women, with obese men showing no further deterioration when compared with their non-obese counterparts. Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism, and masculinization of intermediate metabolism in women with PCOS, further suggesting a role for sex and sex hormones in the regulation of intermediate metabolism.
ArticleNumber 21
Audience Academic
Author Escobar-Morreale, Héctor F.
Cañellas, Nicolau
Insenser, María
Luque-Ramírez, Manuel
Correig, Xavier
Martínez-García, M. Ángeles
Author_xml – sequence: 1
  givenname: Héctor F.
  orcidid: 0000-0002-6890-1644
  surname: Escobar-Morreale
  fullname: Escobar-Morreale, Héctor F.
– sequence: 2
  givenname: M. Ángeles
  surname: Martínez-García
  fullname: Martínez-García, M. Ángeles
– sequence: 3
  givenname: María
  surname: Insenser
  fullname: Insenser, María
– sequence: 4
  givenname: Nicolau
  surname: Cañellas
  fullname: Cañellas, Nicolau
– sequence: 5
  givenname: Xavier
  surname: Correig
  fullname: Correig, Xavier
– sequence: 6
  givenname: Manuel
  surname: Luque-Ramírez
  fullname: Luque-Ramírez, Manuel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37076926$$D View this record in MEDLINE/PubMed
BookMark eNp9k9tq3DAQhk1JadI0L9CLIiiU5GJTHWzLvgoh9BAIpDTttZDl8a6CLW0lOcn2afosvelrdXY3Cbuh1MaWbX3zjzT-52W247yDLHvN6DFjVfk-MsFrMaEcL1pQObl9lu1xmvNJmTO6s_G8mx3EeE3xEHXNRfUi2xWSyrLm5V725wrCOJABkm587wdrIpkH39neuilpFsuX5B1xo-lBBzLoqYNkDQkQvdPOAIlzMCn4aPx88ftXgBvQfSQR7kbdk9YOPsxnNg5EuxbDoxlR2v7UyaKs74h1CcIArdUJHtaxxK0jt34AvNs0I3PfL8wiLjP7Gx0WJC5cG3CeHH45u7w6epU97zAtHNyP-9n3jx--nX2eXFx-Oj87vZiYktdpUjFdQt1K0UFRmzoXXVfRvGO5rJoCBK1kw7pc5ga6QkBFgUIlOMiK16WuSxD72flat_X6Ws2DHXAxymurVh98mCodcJU9KMYaKViFwkWT57JsaFE20HLGodJda1DrZK01HxssgAGXgu63RLdnnJ2pqb9RjDKWC1mgwuG9QvA_RohJDTYa6HvtwI9R8Qr_eclzHPazt0_Qaz8Gh7VaUZRTWWxQU407sK7zmNgsRdWpzEvBhJAMqeN_UHi2gAZCn6J9YDvgaCsAmQR3aarHGNX51ddt9t0GO0MzpVn0_bj0S9wG32yW77FuD-ZGgK8Bg-6MAbpHhFG1bCK1biKFTaRWTaRuMah6EmRsWpkV92j7_4X-BaglJJk
CitedBy_id crossref_primary_10_1186_s13293_023_00547_2
crossref_primary_10_3389_fendo_2023_1273542
crossref_primary_10_3390_metabo14080436
crossref_primary_10_1186_s12905_024_03335_1
crossref_primary_10_1080_10408363_2024_2430775
Cites_doi 10.1007/BF00280883
10.1007/s11306-018-1319-y
10.3390/nu11112566
10.2337/dc07-0642
10.1016/j.tjog.2020.03.006
10.1210/jc.2014-2357
10.1016/j.metabol.2019.01.015
10.1021/ac00101a004
10.1210/jc.2012-3414
10.1039/D0FO02305A
10.14348/molcells.2015.0126
10.1038/nrendo.2018.24
10.1093/humrep/det097
10.1016/j.clnu.2019.03.027
10.3390/biom10010111
10.1371/journal.pgen.1007813
10.1021/acs.jproteome.9b00528
10.1530/EJE-15-0912
10.1210/er.2004-0004
10.1021/ac8011494
10.1016/j.cmet.2009.02.002
10.1016/j.clnu.2020.08.006
10.1001/archinte.166.19.2081
10.1016/j.gendis.2022.04.007
10.1126/science.1241214
10.1038/nrendo.2014.171
10.1161/HYPERTENSIONAHA.113.02468
10.1210/jc.2017-02799
10.1210/jc.2010-2061
10.1210/er.2011-1034
10.1016/0002-9378(81)90746-8
10.1016/j.cmet.2016.09.018
10.1172/JCI135431
10.1016/j.metabol.2018.01.011
10.1002/mnfr.201700425
10.1093/humupd/dmx012
10.1111/andr.12135
10.1016/j.steroids.2009.01.008
10.1210/jc.2012-3438
10.1021/pr901203w
10.1021/ac048630x
10.1016/j.tem.2007.07.003
10.1093/humrep/deu198
10.1373/clinchem.2011.176396
10.1530/EJE-09-0398
10.1002/mnfr.201900928
10.1016/j.mce.2012.07.001
10.1021/ac503651e
10.3390/jcm9072257
10.1159/000519237
10.1093/nar/gks1065
10.1186/s13293-015-0033-y
10.1210/jc.2012-3698
10.1210/jc.2005-2327
10.2337/diacare.22.9.1462
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7R6
7X7
7XB
888
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PSYQQ
QXPDG
7X8
5PM
DOA
DOI 10.1186/s13293-023-00507-w
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
GenderWatch
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
GenderWatch (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
Diversity Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
Diversity Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
GenderWatch (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
GenderWatch
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



Publicly Available Content Database

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Women's Studies
EISSN 2042-6410
EndPage 13
ExternalDocumentID oai_doaj_org_article_11b73188b55b4476b056bed212e8afdc
PMC10114375
A746313371
37076926
10_1186_s13293_023_00507_w
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GrantInformation_xml – fundername: ;
  grantid: PI11/00357; PI15/01686; PIE16/00050; PI18/01122; PI21/00116
GroupedDBID 0R~
4.4
53G
5VS
7R6
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
N8Y
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
QXPDG
RBZ
ROL
RPM
RSV
SBL
SOJ
TUS
UKHRP
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c629t-81a6e9d73fe59c943ff804f1478b5e3087b1f474cef53e80e0e832e78296a96e3
IEDL.DBID M48
ISSN 2042-6410
IngestDate Wed Aug 27 00:08:22 EDT 2025
Thu Aug 21 18:37:37 EDT 2025
Mon Jul 21 10:26:39 EDT 2025
Fri Jul 25 12:04:46 EDT 2025
Tue Jun 17 21:06:16 EDT 2025
Tue Jun 10 20:25:21 EDT 2025
Fri Jun 27 05:47:36 EDT 2025
Thu May 22 21:14:45 EDT 2025
Thu Jan 02 22:52:34 EST 2025
Tue Jul 01 00:41:19 EDT 2025
Thu Apr 24 23:07:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Obesity
Polycystic ovary syndrome
Androgens
Metabolism
Estrogens
Sex
Language English
License 2023. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-81a6e9d73fe59c943ff804f1478b5e3087b1f474cef53e80e0e832e78296a96e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6890-1644
OpenAccessLink https://www.proquest.com/docview/2803020750?pq-origsite=%requestingapplication%
PMID 37076926
PQID 2803020750
PQPubID 2040163
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_11b73188b55b4476b056bed212e8afdc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10114375
proquest_miscellaneous_2803962480
proquest_journals_2803020750
gale_infotracmisc_A746313371
gale_infotracacademiconefile_A746313371
gale_incontextgauss_ISR_A746313371
gale_healthsolutions_A746313371
pubmed_primary_37076926
crossref_primary_10_1186_s13293_023_00507_w
crossref_citationtrail_10_1186_s13293_023_00507_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-19
PublicationDateYYYYMMDD 2023-04-19
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-19
  day: 19
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Biology of sex differences
PublicationTitleAlternate Biol Sex Differ
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References F Alvarez-Blasco (507_CR3) 2006; 166
M Luque-Ramirez (507_CR27) 2014; 63
CJ Lynch (507_CR44) 2014; 10
M Murri (507_CR9) 2018; 86
GA Nagana Gowda (507_CR36) 2015; 87
T Douchi (507_CR50) 1999; 94
JK Zawadzki (507_CR24) 1992
NA Mazer (507_CR30) 2009; 74
F Day (507_CR55) 2018; 14
M Burgos (507_CR52) 2021; 15
HF Escobar-Morreale (507_CR5) 2007; 18
AE Ortiz-Flores (507_CR4) 2019; 93
M Insenser (507_CR11) 2012; 363
M Insenser (507_CR51) 2016; 174
M Liu (507_CR56) 2020; 59
DS Wishart (507_CR33) 2013; 41
HF Escobar-Morreale (507_CR54) 2005; 26
F Gonzalez (507_CR38) 2006; 91
HF Escobar-Morreale (507_CR12) 2012; 58
VK Ridaura (507_CR46) 2013; 341
HF Escobar-Morreale (507_CR14) 2014; 29
MA Martinez-Garcia (507_CR19) 2020; 10
HF Escobar-Morreale (507_CR58) 2017; 23
M Insenser (507_CR23) 2020; 64
M Vinaixa (507_CR35) 2010; 9
JT Pearce (507_CR31) 2008; 80
S Park (507_CR39) 2015; 38
E Diamanti-Kandarakis (507_CR6) 2012; 33
M Matsuda (507_CR29) 1999; 22
M Luque-Ramirez (507_CR26) 2007; 30
MA Martinez-Garcia (507_CR18) 2020; 39
HF Escobar-Morreale (507_CR1) 2018; 14
R Montes-Nieto (507_CR10) 2013; 98
MA Martinez-Garcia (507_CR20) 2021; 12
H Sekizkardes (507_CR48) 2020; 130
MA Martinez-Garcia (507_CR17) 2019; 11
R Fuertes-Martin (507_CR21) 2019; 18
R Hatch (507_CR25) 1981; 140
X Wang (507_CR45) 2011; 96
M Luque-Ramirez (507_CR15) 2013; 28
MA Martinez-Garcia (507_CR8) 2013; 98
O Cloarec (507_CR37) 2005; 77
B Calderon (507_CR57) 2016; 4
DR Matthews (507_CR28) 1985; 28
JK Nicholson (507_CR34) 1995; 67
JM Elbers (507_CR7) 1997; 82
R Montes-Nieto (507_CR16) 2017; 61
E Carmina (507_CR49) 2009; 161
ND Palmer (507_CR42) 2015; 100
D Canueto (507_CR32) 2018; 14
F Mauvais-Jarvis (507_CR13) 2015; 6
M Insenser (507_CR47) 2018; 103
J Li (507_CR53) 2022; 9
CB Newgard (507_CR41) 2009; 9
A Hameed (507_CR40) 2020; 9
CB Newgard (507_CR43) 2017; 25
S Moncayo (507_CR22) 2021; 40
S Borruel (507_CR2) 2013; 98
References_xml – volume: 28
  start-page: 412
  year: 1985
  ident: 507_CR28
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 14
  start-page: 24
  year: 2018
  ident: 507_CR32
  publication-title: Metabolomics
  doi: 10.1007/s11306-018-1319-y
– volume: 11
  start-page: E2566
  year: 2019
  ident: 507_CR17
  publication-title: Nutrients
  doi: 10.3390/nu11112566
– volume: 30
  start-page: 2309
  year: 2007
  ident: 507_CR26
  publication-title: Diabetes Care
  doi: 10.2337/dc07-0642
– volume: 59
  start-page: 372
  year: 2020
  ident: 507_CR56
  publication-title: Taiwan J Obstet Gynecol
  doi: 10.1016/j.tjog.2020.03.006
– volume: 100
  start-page: E463
  year: 2015
  ident: 507_CR42
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-2357
– volume: 93
  start-page: 86
  year: 2019
  ident: 507_CR4
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2019.01.015
– volume: 67
  start-page: 793
  year: 1995
  ident: 507_CR34
  publication-title: Anal Chem
  doi: 10.1021/ac00101a004
– volume: 98
  start-page: E388
  year: 2013
  ident: 507_CR8
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-3414
– volume: 12
  start-page: 1051
  year: 2021
  ident: 507_CR20
  publication-title: Food Funct
  doi: 10.1039/D0FO02305A
– volume: 38
  start-page: 587
  year: 2015
  ident: 507_CR39
  publication-title: Mol Cells
  doi: 10.14348/molcells.2015.0126
– volume: 14
  start-page: 270
  year: 2018
  ident: 507_CR1
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2018.24
– volume: 28
  start-page: 1908
  year: 2013
  ident: 507_CR15
  publication-title: Hum Reprod
  doi: 10.1093/humrep/det097
– volume: 39
  start-page: 876
  year: 2020
  ident: 507_CR18
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2019.03.027
– volume: 10
  start-page: E111
  year: 2020
  ident: 507_CR19
  publication-title: Biomolecules
  doi: 10.3390/biom10010111
– volume: 14
  year: 2018
  ident: 507_CR55
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1007813
– volume: 18
  start-page: 4038
  year: 2019
  ident: 507_CR21
  publication-title: J Proteome Res
  doi: 10.1021/acs.jproteome.9b00528
– volume: 174
  start-page: 389
  year: 2016
  ident: 507_CR51
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-15-0912
– volume: 26
  start-page: 251
  year: 2005
  ident: 507_CR54
  publication-title: Endocr Rev
  doi: 10.1210/er.2004-0004
– volume: 80
  start-page: 7158
  year: 2008
  ident: 507_CR31
  publication-title: Anal Chem
  doi: 10.1021/ac8011494
– volume: 9
  start-page: 311
  year: 2009
  ident: 507_CR41
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.02.002
– volume: 82
  start-page: 2044
  year: 1997
  ident: 507_CR7
  publication-title: J Clin Endocrinol Metab
– volume: 40
  start-page: 1241
  year: 2021
  ident: 507_CR22
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2020.08.006
– volume: 166
  start-page: 2081
  year: 2006
  ident: 507_CR3
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.166.19.2081
– volume: 9
  start-page: 1478
  year: 2022
  ident: 507_CR53
  publication-title: Genes Dis
  doi: 10.1016/j.gendis.2022.04.007
– volume: 341
  start-page: 1241214
  year: 2013
  ident: 507_CR46
  publication-title: Science
  doi: 10.1126/science.1241214
– volume: 10
  start-page: 723
  year: 2014
  ident: 507_CR44
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2014.171
– volume: 63
  start-page: 624
  year: 2014
  ident: 507_CR27
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.113.02468
– volume: 103
  start-page: 2552
  year: 2018
  ident: 507_CR47
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2017-02799
– volume: 96
  start-page: 885
  year: 2011
  ident: 507_CR45
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-2061
– volume: 33
  start-page: 981
  year: 2012
  ident: 507_CR6
  publication-title: Endocr Rev
  doi: 10.1210/er.2011-1034
– volume: 140
  start-page: 815
  year: 1981
  ident: 507_CR25
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/0002-9378(81)90746-8
– volume: 25
  start-page: 43
  year: 2017
  ident: 507_CR43
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2016.09.018
– volume: 130
  start-page: 3592
  year: 2020
  ident: 507_CR48
  publication-title: J Clin Investig
  doi: 10.1172/JCI135431
– volume: 86
  start-page: 49
  year: 2018
  ident: 507_CR9
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2018.01.011
– volume: 61
  start-page: 1700425
  year: 2017
  ident: 507_CR16
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201700425
– volume: 23
  start-page: 390
  year: 2017
  ident: 507_CR58
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dmx012
– volume: 4
  start-page: 62
  year: 2016
  ident: 507_CR57
  publication-title: Andrology
  doi: 10.1111/andr.12135
– volume: 74
  start-page: 512
  year: 2009
  ident: 507_CR30
  publication-title: Steroids
  doi: 10.1016/j.steroids.2009.01.008
– volume: 98
  start-page: E576
  year: 2013
  ident: 507_CR10
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-3438
– volume: 9
  start-page: 2527
  year: 2010
  ident: 507_CR35
  publication-title: J Proteome Res
  doi: 10.1021/pr901203w
– volume: 77
  start-page: 1282
  year: 2005
  ident: 507_CR37
  publication-title: Anal Chem
  doi: 10.1021/ac048630x
– volume: 18
  start-page: 266
  year: 2007
  ident: 507_CR5
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2007.07.003
– volume: 29
  start-page: 2083
  year: 2014
  ident: 507_CR14
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deu198
– volume: 94
  start-page: 337
  year: 1999
  ident: 507_CR50
  publication-title: Obstet Gynecol
– volume: 58
  start-page: 999
  year: 2012
  ident: 507_CR12
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2011.176396
– volume: 161
  start-page: 583
  issue: 4
  year: 2009
  ident: 507_CR49
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0398
– volume: 64
  year: 2020
  ident: 507_CR23
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201900928
– volume: 363
  start-page: 10
  year: 2012
  ident: 507_CR11
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2012.07.001
– volume: 87
  start-page: 706
  year: 2015
  ident: 507_CR36
  publication-title: Anal Chem
  doi: 10.1021/ac503651e
– start-page: 377
  volume-title: Polycystic ovary syndrome
  year: 1992
  ident: 507_CR24
– volume: 9
  start-page: 2257
  year: 2020
  ident: 507_CR40
  publication-title: J Clin Med
  doi: 10.3390/jcm9072257
– volume: 15
  start-page: 335
  year: 2021
  ident: 507_CR52
  publication-title: Sex Dev
  doi: 10.1159/000519237
– volume: 41
  start-page: D801
  year: 2013
  ident: 507_CR33
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gks1065
– volume: 6
  start-page: 14
  year: 2015
  ident: 507_CR13
  publication-title: Biol Sex Differ
  doi: 10.1186/s13293-015-0033-y
– volume: 98
  start-page: 1254
  year: 2013
  ident: 507_CR2
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-3698
– volume: 91
  start-page: 1508
  year: 2006
  ident: 507_CR38
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-2327
– volume: 22
  start-page: 1462
  year: 1999
  ident: 507_CR29
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.9.1462
SSID ssj0000399238
Score 2.31036
Snippet The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the hypothesis, using...
Background The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the...
BackgroundThe polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged the...
Abstract Background The polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiometabolic comorbidities. We here challenged...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 21
SubjectTerms Androgens
Body fat
Body mass index
Carbohydrates
Comorbidity
Estrogens
Female
Humans
Insulin resistance
Magnetic Resonance Spectroscopy
Male
Metabolism
Metabolites
Metabolomics
NMR
Nuclear magnetic resonance
Nuclear magnetic resonance spectroscopy
Obesity
Obesity - metabolism
Ovaries
Physiological aspects
Polycystic Ovary Syndrome
Protons
Sex
Sex Characteristics
Sex hormones
Sexual dimorphism
Stein-Leventhal syndrome
Type 2 diabetes
Young Adult
Young adults
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wq3iwUMAipIBQ1Thw_jqWiKkg8RKnUm2UndrvSblJtdqn23_BbuPC3mHGS1UZIcOGQw8ZjKTsznkcy8w0hL4ssDZXPQhKKQiYQ3_rEubRKhHMQ3eu8tB5f6H_8JE7O-Ifz4nxr1BfWhHXwwB3jDhhzEvROuaJwnEvhwGM7X4HF9cqGqkTrCz5vK5mKNhjxVnM1dMkocdDiRHX8ZAlXCkFQcj3yRBGw_0-zvOWXxjWTW07o-BbZ7aNHetg99W1yw9d3yG6cQrnf0r4m8C75BRZgNadzvwQRz7DvuKXdcG5wVNSt8QfEfLRGMGO7oHN7UWMzI4Xcu0EEDk9jByYiXTZX658_EOcJ9JS2EaCZViBgkM-0nVNbV7Adq1mnQ0snbQJFFIpF7EpZ-uE5kHxa04j5QPH9L71qZutyjUjRtPluF2s64CfQV1-OPp--vkfOjt99OzpJ-okNSSkyvUwUs8LrSubBF7rUPA9BpTwwLkF-HsEHHQtc8tKHIvcq9akHi-IhStHCauHz-2Snbmr_kNCqyBRLrVIeEeK10qAA0ln8bsmZrrIJYYP0TNnDmeNUjZmJaY0SppO4AYmbKHFzPSFvNnuuOjCPv1K_RaXYUCIQd7wB6ml69TT_Us8JeYYqZbqu1o05MYeSi5zluWQT8iJSIBhHjdU-F3bVtub96dcR0X5PFBr4l6XtmyeAV4jfNaLcG1GCtSjHy4Num95atQYnlEHaAMHjhDzfLONOrMCrfbPqaLTIuAKaB91R2HAml6kUOhMTokaHZMS68Uo9vYxY5gwT8lwWj_4Hsx-Tm1k84Dxheo_sLBcr_wRixqV7Gs3Db_uTba4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLhUvAkUMAipIBQ1D8ePEyoVVUHiIUql3iw7sbcr7SbLZpdq_yC_ixknWRoh9bCHrMdS4nl4PJ75hpDXRZb4ymU-9kUhYvBvXWxtUsXcWvDuVV4ahwH9L1_5yRn7fF6c9wG3tk-rHGxiMNRVU2KM_AC7KIFrAxvc-8WvGLtG4e1q30LjJrmF0GUo1eJcbGMsCaKu5nKolZH8oMW-6nhxCb8EXKH4crQfBdj-_43zld1pnDl5ZSs6vkN2ex-SHnZMv0tuuPoe2Q29KPdb2mcG3id_wA6s53TuVsDoGVYft7Rr0Q3bFbUbfADPj9YIaWyWdG4mNZY0UjiBN4jD4Wiow0S8y2axoQj2BMJK24DSTCvgMjBp2s6pqSuYjSmt06GukzaeIhTFMpSmrNzwGkg-rWkAfqAYBKaLZrYpNwgXTZvfZrmhA4gCffP96Nvp2wfk7Pjjz6OTuG_bEJc8U6tYpoY7VYncu0KViuXey4T5lAlpC4cIhDb1TLDS-SJ3MnGJA7PiwFVR3Cju8odkp25q95jQqshkmhgpHcLEK6ksSJQ1eHnJUlVlEUkH5umyxzTH1hozHc42kuuO4RoYrgPD9WVE3m3nLDpEj2upP6BMbCkRjTv80SwnuldumGsF2Eb4vMIyJrgFr9K6CrwCJ42vyoi8QInSXWnr1qboQ8F4nua5SCPyKlAgIkeNKT8Ts25b_en0x4hovyfyDXxlafoKClgrBPEaUe6NKMFklOPhQbR1b7Ja_U_BIvJyO4wzMQ2vds26o1E8YxJoHnWasF2ZXCSCq4xHRI50ZLR045F6ehEAzVM8leeieHL9ez0lt7OguSxO1R7ZWS3X7hm4hCv7POj9X6ZtY8k
  priority: 102
  providerName: ProQuest
Title Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS)
URI https://www.ncbi.nlm.nih.gov/pubmed/37076926
https://www.proquest.com/docview/2803020750
https://www.proquest.com/docview/2803962480
https://pubmed.ncbi.nlm.nih.gov/PMC10114375
https://doaj.org/article/11b73188b55b4476b056bed212e8afdc
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELf28cLLxDeFUQxCGghl5MPxxwNC3bRpVNqYVirtLYoTp1Rqk9K0jPyD_F3cOUm1iAkeoir1uWrOd-efHd_vCHkb-m6WGj9zsjAUDuBb42jtpg7XGtC9CpLY4Ib--QU_G7PhdXi9RdpyR40CyzuXdlhParycHf76UX0Gh_9kHV7yjyUWS8e3kXC5gG-cm22yCzOTwIoG5w3ct5EZWVhtcWsfs1I489w2j-bOn-nMVZbS_-_AfWvm6p6qvDVNnd4new2-pIPaIB6QLZM_JHu2TuVBSZtTg4_Ib4gR6zmdmxUYwQwzk0tal--GqYzqCm8AFdIc6Y7jJZ3HkxzTHSmszgvk6DDU5mgiF2axqCgSQYFCaWkZnGkKFgADOC3nNM5T6I3HXadtzictMoo0FUubtrIy7d9A8WlOLSkExQ1iuihmVVIhlTQtfsbLirYEC_Td5fHX0fvHZHx68u34zGlKOjgJ99XKkV7MjUpFkJlQJYoFWSZdlnlMSB0aZCfUXsYES0wWBka6xjUQcgzAGMVjxU3whOzkRW6eEZqGvvTcWEqDFPJKKg3WpmN8sck8lfo94rWDFyUN3zmW3ZhFdt0jeVQPeAQDHtkBj2565MOmz6Jm-_in9BHaxEYSmbrtF8VyEjWOD321gLgJjxdqxgTXgDi1SQExGBlnadIjr9CiojrtdRNvooFgPPCCQHg98sZKIFtHjseBJvG6LKMvo6uO0EEjlBXwlEncZFeArpDgqyO535GEcJJ0m1vTjlpvjLCEGawrAF32yOtNM_bEI3q5Kda1jOI-kyDztPaEjWYC4QqufN4jsuMjHdV1W_Lpd0t27uGKPRDh8__q6QW551vnZY6n9snOark2LwExrnSfbItr0Se7g8FwNITPo5OLy6u-3X_p2xDxB6K3bzc
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcoBLxRtDoQsCFVRZ9XMfB4RKoWroA0RbKbfFa69DpMQOcUKUP8XP4Hcxs7ZDLaTeesgh2dnI3pmdmZ2d-YaQV3Hg5ZkJcjePY-6Cf2tcrb3MZVqDdy_DNDEY0D85ZYcX0ed-3F8jv9taGEyrbHWiVdRZmWKMfBe7KIFrAwbu_eSni12j8Ha1baFRi8WRWS7gyFa9630E_r4OgoNP5_uHbtNVwE1ZIGeu8BNmZMbD3MQylVGY58KLcj_iQscGAfK0n0c8Sk0eh0Z4xjMg9QYsqWSJZCaE_71BboLh9fCwx_t8FdPxEOU1FG1tjmC7FfZxx4tS-HjgermLjv2zbQL-NwaXrGE3U_OS6Tu4QzYan5Xu1UJ2l6yZ4h7ZsL0vtyvaZCLeJ39A78zHdGxmIFgjrHauaN0SHMwj1Uv8Ap4mLRBCOZnScTIosISSwom_RNwPQ23dJ-JrlpMlRXAp2By0sqjQNAOpAqEYVmOaFBnMxhTaYVtHSsucIvTF1JbCzEz7GEg-LKgFmqAYdKaTcrRMlwhPTctfyXRJW9AG-ubr_peztw_IxbUw9CFZL8rCPCY0iwPhe4kQBmHppZAaJFgneFka-TILHOK3zFNpg6GOrTxGyp6lBFM1wxUwXFmGq4VDdlZzJjWCyJXUH1AmVpSI_m1_KKcD1SgTmKs56GJ4vVhHEWcavFhtMvBCjEjyLHXIFkqUqktpVzpM7fGIhX4Yct8hLy0FIoAUmGI0SOZVpXpn3zpE2w1RXsJbpklTsQFrhaBhHcrNDiWoqLQ73Iq2alRkpf5taIe8WA3jTEz7K0w5r2kkCyIBNI_qnbBamZB7nMmAOUR09khn6bojxfCHBVD3MQoQ8vjJ1c-1RW4dnp8cq-Pe6dFTcjuwuzhyfblJ1mfTuXkG7uhMP7c6gJLv1610_gKY0qAQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+metabolomics+profiling+by+proton+nuclear+magnetic+resonance+spectroscopy+reveals+sexual+dimorphism+and+masculinization+of+intermediate+metabolism+in+women+with+polycystic+ovary+syndrome+%28PCOS%29&rft.jtitle=Biology+of+sex+differences&rft.au=Insenser%2C+Mar%C3%ADa&rft.au=Ca%C3%A9ellas%2C+Nicolau&rft.au=Escobar-Morreale%2C+H%C3%A9ctor+F&rft.au=Correig%2C+Xavier&rft.date=2023-04-19&rft.pub=BioMed+Central+Ltd&rft.issn=2042-6410&rft.eissn=2042-6410&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1186%2Fs13293-023-00507-w&rft.externalDBID=n%2Fa&rft.externalDocID=A746313371
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6410&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6410&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6410&client=summon